Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ginecol Obstet Mex ; 65: 87-91, 1997 Mar.
Article in Spanish | MEDLINE | ID: mdl-9190357

ABSTRACT

A prospective study was done at the Clinic for Sexually Transmitted Diseases of the Department of Infectology, Instituto Nacional de Perinatología, Mexico City, in order to validate the fresh wet mount examination as a confirmatory test for vaginal candidiasis. Ninety six patients with cervico-vaginal infection were included, 22 of them had clinical candidiasis (22.9%). The fresh wet mount examination showed the presence of yeast and/or pseudomycelium in all 2 samples (100%). The presence of Candida in the cultures was confirmed in 18 of the 22 specimens (81.8). Negative in 71/96 (73.9%) (Three cultures were not processed). The fresh wet mount examination had a sensitivity of 100% and a specificity of 94.8%. The positive predictive value was 88.8% while the negative predictive value was 100%. It can be concluded that the fresh wet mount examination is very recommendable, useful, economic and easy to practice at the physician's office for the confirmation of vaginal candidiasis.


Subject(s)
Candida/isolation & purification , Candidiasis, Vulvovaginal/diagnosis , Vagina/microbiology , Adolescent , Adult , Female , Humans , Microscopy , Prospective Studies , Sensitivity and Specificity , Vaginal Smears
2.
Ginecol Obstet Mex ; 61: 261-4, 1993 Sep.
Article in Spanish | MEDLINE | ID: mdl-8406112

ABSTRACT

Genital tract infections by Chlamydia trachomatis associated to sterility and infertility problems as well as perinatal complications have become increasingly frequent. Azithromycin is a new macrolide with a lower activity spectrum than erythromycin and a longer half life as well as less secondary effects. The objective of the study was to evaluate the safety and efficiency of Azithromycin on genital tract infection by C. trachomatis. MATERIAL AND METHODOLOGY. A total of 30 nonpregnant women between the ages of 19 and 35 were studied; 70% had only one sexual partner. In order to insure the presence of C. trachomatis as unique pathogen, cervicovaginal sampling, clinical evaluation and gynecologic exploration were undertaken. One dose of 1 g orally of Azithromycin was administered evaluating microbiologic and clinical remission at days 7-10, 12-16 and 33-37 after treatment. RESULTS. Two patients abandoned the study; global criteria of the evaluation were good to excellent in 17 cases; moderate to sufficient in six and poor in five. None of the cases reported secondary reactions. Results showed that Azithromycin treatment of cervicitis by C. trachomatis is useful with the advantage of unique dose administration.


Subject(s)
Azithromycin/therapeutic use , Chlamydia Infections/drug therapy , Chlamydia trachomatis/isolation & purification , Uterine Cervicitis/drug therapy , Adolescent , Adult , Azithromycin/pharmacology , Chlamydia Infections/complications , Chlamydia Infections/microbiology , Chlamydia trachomatis/drug effects , Dose-Response Relationship, Drug , Female , Humans , Infertility, Female/drug therapy , Infertility, Female/etiology , Infertility, Female/microbiology , Uterine Cervicitis/complications , Uterine Cervicitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...